868 results on '"Koch-Nolte, Friedrich"'
Search Results
2. Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice
3. The classical pathway triggers pathogenic complement activation in membranous nephropathy
4. Microglial P2X4 receptors are essential for spinal neurons hyperexcitability and tactile allodynia in male and female neuropathic mice
5. Introduction of a novel chimeric active immunization mouse model of PLA2R1-associated membranous nephropathy
6. Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesions
7. Interferon regulatory factor 4 controls effector functions of CD8⁺ memory T cells
8. Nanobody‐based heavy chain antibodies and chimeric antibodies.
9. Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice
10. Generation and characterization of antagonistic anti-human CD39 nanobodies
11. Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation
12. The TRPM2 ion channel regulates metabolic and thermogenic adaptations in adipose tissue of cold-exposed mice
13. An antigen-specific chimeric autoantibody receptor NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells
14. Nanobodies: new avenue to treat kidney disease
15. Development of Antibody and Nanobody Tools for P2X7
16. Enhanced Transduction of P2X7-Expressing Cells with Recombinant rAAV Vectors
17. A P2rx7 Passenger Mutation Affects the Vitality and Function of T cells in Congenic Mice
18. Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
19. Increased surface P2X4 receptor regulates anxiety and memory in P2X4 internalization-defective knock-in mice
20. Different localization of P2X4 and P2X7 receptors in native mouse lung - lack of evidence for a direct P2X4-P2X7 receptor interaction.
21. A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients
22. The P2X7 ion channel is dispensable for energy and metabolic homeostasis of white and brown adipose tissues
23. Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation
24. Novel biologics targeting the P2X7 ion channel
25. Generation and characterization of antagonistic anti-human CD39 nanobodies.
26. Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation.
27. ADP-Ribosylation of P2X7: A Matter of Life and Death for Regulatory T Cells and Natural Killer T Cells
28. P2X7-mediated ATP secretion is accompanied by depletion of cytosolic ATP
29. Deviant reporter expression and P2X4 passenger gene overexpression in the soluble EGFP BAC transgenic P2X7 reporter mouse model
30. An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells
31. A PKR-Like Eukaryotic Initiation Factor 2α Kinase from Zebrafish Contains Z-DNA Binding Domains Instead of dsRNA Binding Domains
32. IRF4 is required for migration of CD4+ T cells to the intestine but not for Th2 and Th17 cell maintenance
33. A Polymorphic Dinucleotide Repeat in the Rat Nucleolin Gene Forms Z-DNA and Inhibits Promoter Activity
34. Flow Cytometry of Membrane Purinoreceptors
35. ZBP1 subcellular localization and association with stress granules is controlled by its Z-DNA binding domains
36. Data from Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies
37. Supplementary Figures 1-3 and Table1 from Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies
38. Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
39. Macrophages and glia are the dominant P2X7-expressing cell types in the gut nervous system—No evidence for the role of neuronal P2X7 receptors in colitis
40. A transplant “immunome” screening platform defines a targetable epitope fingerprint of multiple myeloma
41. Monitoring the Sensitivity of T Cell Populations Towards NAD+ Released During Cell Preparation
42. Monitoring Expression and Enzyme Activity of Ecto-ARTCs
43. P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis
44. Macrophages and glia are the dominant P2X7-expressing cell types in the gut nervous system – no evidence for a role of neuronal P2X7 receptors in colitis
45. Role of Liver CD38 in the Regulation of Metabolic Pathways during Cold-Induced Thermogenesis in Mice
46. Origin, distribution, and function of three frequent coding polymorphisms in the gene for the human P2X7 ion channel
47. Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors
48. A simple, sensitive, and low‐cost FACS assay for detecting antibodies against the native SARS‐CoV‐2 spike protein
49. CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy
50. P2X7 is expressed on human innate‐like T lymphocytes and mediates susceptibility to ATP‐induced cell death
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.